By Julie Anderson, Omaha World Herald, January 20, 2022 A measure slated for a Friday hearing in the Nebraska Legislature would make sure patients seeking ...
Yesterday, State Senator John Arch introduced a bill requiring providers to notify patients if they are offering a stem cell treatment that is not FDA ...
By David Crouse, PhD In the fall of 2019 edition of this newsletter, I provided an update on the problems with “direct-to-consumer marketing” of stem ...
The US Food and Drug Administration (FDA) has authority to regulate regenerative medicine products, including stem cell products and exosome products. There is a lot ...
Hope is such a fragile thing. We cling to it in bad times. It offers us a sense that we can bear whatever hardships we ...
